Refresh

Bacil Pharma Ltd. - Research Center

524516 BACPHAR Group (XT) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Sales

- - - - -

Operating profit

-0.21 -3.91 -0.31 -0.45 -0.43

Interest

- - - - -

Gross profit

-0.10 -3.86 -0.23 -0.31 -0.33

EPS (Rs)

-0.17 -6.55 -0.41 -0.54 -0.58
Annual  results in details
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Other income

0.11 0.06 0.07 0.14 0.09

Stock adjustment

- - - - -

Raw material

- - - - -

Power and fuel

- - - - -

Employee expenses

0.09 0.06 0.05 0.09 0.08

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

0.13 3.85 0.26 0.36 0.35

Provisions made

- - - - -

Depreciation

- - - 0.01 0.01

Taxation

- - - - -

Net profit / loss

-0.10 -3.86 -0.24 -0.32 -0.34

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

5.89 5.89 5.89 5.89 5.89

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

- - - - -

GPM (%)

- - - - -

NPM (%)

- - - - -
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com